For many small and medium-sized enterprises (SMEs) in the life sciences sector, the path to scaling up, innovation and expansion can be blocked by regional limitations, resource constraints, and the complexities of global markets access.
This was the case for Rodim, a healthcare company with over 25 years of experience and with operations across Central America with a robust portfolio that includes cardiometabolic therapies, pain management solutions, and multivitamins.
Paving the way for Accelerated Growth
With a robust portfolio that includes cardiometabolic therapies, pain management solutions, and multivitamins, alongside ambitious goals to scale rapidly, attract global partners, and foster product innovation, Rodim recognized the need for strategic input to turn their vision into reality. By partnering with KYBORA and Bpeace, the company gained the insights, structure and market expertise necessary to execute its vision effectively.
KYBORA and Bpeace provided key recommendations to strengthen Rodim’s internal framework, including identifying critical roles in market analysis and business development. This strategic approach enabled Rodim to build a stronger team, scale operations, and foster innovation enhancing its capacity for sustainable expansion.
Strengthening Quality & Manufacturing Excellence
One of the company’s most significant accomplishments was the successful recertification of Good Manufacturing Practices (GMP). This achievement reinforces their dedication to excellence but also opens new maquila opportunities, setting the stage for further business expansion and credibility in the healthcare industry.
What they needed to progress beyond these challenges was strategic input from an experienced partner, with the knowledge, insights and network to help them scale effectively and sustainably.
New Product Launches That Exceeded Expectations
2024 was also a remarkable year for product innovation at Rodim. The company also sought to expand its product portfolio strategically, and successfully launched five new products that surpassed their sales expectations and cementing their reputation as a product innovator. This successful rollout reflects Rodim’s ability to understand market needs and respond with effective healthcare solutions.
Looking ahead, Rodim plans to expand into new therapeutic classes with seven launches in the metabolic segment slated for the coming year, demonstrating their commitment to continuous growth and innovation.
Export Growth: A Major Revenue Driver
The company’s international presence has also substantial growth, with exports now accounting for 43% of total revenue. The company has successfully extended its reach to countries such as Guatemala, Honduras, and Nicaragua. This expansion not only enhances Rodim’s market presence but also solidifies their reputation as a key player in the regional healthcare industry.
In 2025, Rodim plans to further extend their footprint by registering products in the Dominican Republic, signaling their ongoing commitment to growth and market diversification.
Future Plans and Workforce Expansion
Rodim’s growth trajectory also includes significant workforce expansion. The company has grown its team to 140 employees and is planning to increase this number to 163 by 2025. This planned expansion underscores Rodim’s commitment to scaling their operations and supporting their ambitious growth plans.
By investing in their workforce, Rodim is not only enhancing their operational capabilities but also contributing to job creation and economic development in the regions they serve.
The Outcome: Transformation Through Execution of Strategic Goals
Rodim has marked 2024 as a year of remarkable achievements, reinforcing its commitment to excellence and growth. Through its collaboration with KYBORA and Bpeace, Rodim translated strategic goals into measurable outcomes.
The transformation has been recognized across the organization.
As Guillermo Menendez, Executive Director at Rodim, shared:
“We are incredibly grateful for the work KYBORA has done. Their insight and support have had a lasting impact on our team and our strategy. The progress we’ve made – new products, expanded markets, GMP recertification – has been remarkable. We’re now operating with a clarity and confidence that wouldn’t have been possible without their guidance.”
Ernesto Neumann, Senior Advisor at KYBORA, states:
“At KYBORA, we are proud to have played a key role in driving potential growth. Our partnership with Rodim is a testament of how innovation, strategic vision and collaboration can turn business goals into reality. By optimizing Rodim’s portfolio, refining their product strategy and building a robust internal structure, we have not only realized their growth ambitious but also unlock new growth opportunities. This collaboration exemplifies our commitment to delivering long-term value, driving sustainable success for our clients, and shaping the future of our industry.“
Cécile Ney, Impact Lead at Bpeace, shares:
“A good job changes everything. At Bpeace, we believe employment is a powerful driver of opportunity and progress. That’s why we focus on growing businesses and creating jobs in communities where they’re needed most. By pairing small and medium-size businesses with volunteer business experts, we help spark growth that uplifts entire families and strengthens communities. The work that Rodim and KYBORA did exemplifies the kind of business-driven progress that will shape a stronger future for Central America.”
